2 New Studies: Ketamine for Fibromyalgia & Chronic Nerve Pain: Repeat Infusions VS Ketamine with Psychotherapy
Two new 2026 studies: repeat high-dose ketamine infusions gave a third of fibromyalgia patients 2-year relief, while ketamine plus psychotherapy beat ketamine alone.
Brain Scans Show How Ketamine Lifts Treatment-Resistant Depression
A March 2026 study published in Molecular Psychiatry uses PET brain imaging to offer a clearer look at how ketamine may rapidly improve symptoms in treatment-resistant depression.
New ASKP3 Ketamine Guidelines: Key Takeaways for IV Ketamine Treatment
New (May 2026) ASKP3 ketamine guidelines explain IV ketamine induction, maintenance, dosing, and safety for effective depression treatment.
New Study Says Psychedelics Are No Better than Antidepressants; We Say There’s More to the Story
A study published in JAMA in March of 2026 says psychedelics are no better than antidepressants for depression. Here’s why the headline misses key context on side effects, duration, and healing.
Ketamine Dosing: Routes of Administration, Bioavailability, and What the Research Shows
Ketamine dosing explained: IV, IM, intranasal, and oral routes compared: bioavailability, clinical research, and how dosing decisions are made.